These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7509257

  • 1. Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Lorelli W, Thoolen MJ, Ramachandran N, Jackson S, De Grado W, Reilly TM.
    Cardiology; 1993; 83(5-6):374-82. PubMed ID: 7509257
    [Abstract] [Full Text] [Related]

  • 2. Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802.
    Mousa SA, Olson RE, Bozarth JM, Lorelli W, Forsythe MS, Racanelli A, Gibbs S, Schlingman K, Bozarth T, Kapil R, Wityak J, Sielecki TM, Wexler RR, Thoolen MJ, Slee A, Reilly TM, Anderson PS, Friedman PA.
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):169-76. PubMed ID: 9700976
    [Abstract] [Full Text] [Related]

  • 3. Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs.
    Mousa SA, Flint S, Lorelli W, Hassell S, Bozarth J, De Grado W, Reilly TM.
    Thromb Res; 1994 Oct 15; 76(2):109-19. PubMed ID: 7863463
    [Abstract] [Full Text] [Related]

  • 4. Glycoprotein IIb/IIIa receptor antagonists inhibit the development of platelet procoagulant activity.
    Pedicord DL, Thomas BE, Mousa SA, Dicker IB.
    Thromb Res; 1998 Jun 15; 90(6):247-58. PubMed ID: 9700855
    [Abstract] [Full Text] [Related]

  • 5. Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs.
    Mousa SA, Mu DX, Lucchesi BR.
    Stroke; 1997 Apr 15; 28(4):830-5; discussion 835-6. PubMed ID: 9099204
    [Abstract] [Full Text] [Related]

  • 6. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Mousa SA, Forsythe MS, Diemer M, Bozarth JM, Reilly TM.
    Coron Artery Dis; 1994 Nov 15; 5(11):919-27. PubMed ID: 7719524
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK.
    Circulation; 1994 Jan 15; 89(1):3-12. PubMed ID: 8281661
    [Abstract] [Full Text] [Related]

  • 8. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
    Satoh T, Kouns WC, Yamashita Y, Kamiyama T, Steiner B.
    Biochem Biophys Res Commun; 1994 Oct 14; 204(1):325-32. PubMed ID: 7524499
    [Abstract] [Full Text] [Related]

  • 9. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
    Mousa SA, Bozarth JM, Lorelli W, Forsythe MS, Thoolen MJ, Slee AM, Reilly TM, Friedman PA.
    J Pharmacol Exp Ther; 1998 Sep 14; 286(3):1277-84. PubMed ID: 9732389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous and oral antiplatelet/antithrombotic efficacy and specificity of XR300, a novel nonpeptide platelet GPIIb/IIIa antagonist.
    Mousa SA, Forsythe M, Wityak J, Bozarth J, Mu DX.
    J Cardiovasc Pharmacol; 1998 Mar 14; 31(3):441-8. PubMed ID: 9514190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728.
    Tsao PW, Forsythe MS, Mousa SA.
    Thromb Res; 1997 Oct 15; 88(2):137-46. PubMed ID: 9361367
    [Abstract] [Full Text] [Related]

  • 16. Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban.
    Mousa SA, Bozarth JM, Naik UP, Slee A.
    Br J Pharmacol; 2001 Jun 15; 133(3):331-6. PubMed ID: 11375248
    [Abstract] [Full Text] [Related]

  • 17. The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonist.
    Nichols AJ, Vasko JA, Valocik RE, Kopaciewicz LJ, Storer BL, Ali FE, Romoff T, Calvo R, Samanen JM.
    Thromb Res; 1994 Jul 15; 75(2):143-56. PubMed ID: 7974388
    [Abstract] [Full Text] [Related]

  • 18. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
    Mousa SA, Bozarth JM, Edwards S, Carroll T, Barrett J.
    Coron Artery Dis; 1998 Jul 15; 9(2-3):131-41. PubMed ID: 9647415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.